Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_assertion type Assertion NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_head.
- NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_assertion description "[In oxaliplatin-treated patients, carriers of one or two T variants of Asn118Asn ERCC1 SNP had a lower risk for neutropenia(OR = 0.205; 95 % CI = 0.061?0.690; P = 0.01) [corrected].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_provenance.
- NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_assertion evidence source_evidence_literature NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_provenance.
- NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_assertion SIO_000772 23543295 NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_provenance.
- NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_assertion wasDerivedFrom befree-2016 NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_provenance.
- NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_assertion wasGeneratedBy ECO_0000203 NP1065128.RAH-6X7l9tw14zMVSSIp2bTp_KZdoxu4so6Btm3QlAdnI130_provenance.